241 related articles for article (PubMed ID: 3637200)
1. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.
Lau WY; Teoh-Chan CH; Fan ST; Lau KF
J Hyg (Lond); 1986 Jun; 96(3):419-23. PubMed ID: 3637200
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Alvarez S; Jones M; Berk SL
Antimicrob Agents Chemother; 1985 Nov; 28(5):689-90. PubMed ID: 3853963
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Graninger W; Leitha T; Havel M; Georgopoulos A
Infection; 1984; 12(4):293-5. PubMed ID: 6092279
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Guenthner SH; Wenzel RP
Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
[TBL] [Abstract][Full Text] [Related]
5. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
Haag R
Infection; 1986; 14(1):38-43. PubMed ID: 3957435
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of fosfomycin-penicillin M and penicillin M-gentamycin. Apropos of 35 severe infections caused by methicillin-sensitive Staphylococcus aureus].
Baron D; Touze MD; Tasseau F; Reynaud A; Derriennic M; Courtieu AL
Rev Med Interne; 1987; 8(1):109-14. PubMed ID: 3645705
[TBL] [Abstract][Full Text] [Related]
8. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
[TBL] [Abstract][Full Text] [Related]
9. Effects of antibiotic combinations on methicillin-resistant Staphylococcus aureus in vitro.
Chang SC; Hsieh WC; Luh KT; Ho SW
Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):488-92. PubMed ID: 2794948
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus.
Utsui Y; Ohya S; Magaribuchi T; Tajima M; Yokota T
Antimicrob Agents Chemother; 1986 Dec; 30(6):917-22. PubMed ID: 3468883
[TBL] [Abstract][Full Text] [Related]
11. Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits.
Chavanet P; Muggeo E; Waldner A; Dijoux S; Caillot D; Portier H
Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):271-5. PubMed ID: 2351143
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Thauvin C; Lemeland JF; Humbert G; Fillastre JP
Antimicrob Agents Chemother; 1988 Jun; 32(6):919-21. PubMed ID: 3166360
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
Kono K; Takeda S; Tatara I; Arakawa K; Tanaka H; Miyake S; Minamikawa H; Hoshino H; Sato M; Hattori F
Jpn J Antibiot; 1994 Jun; 47(6):798-803. PubMed ID: 8072189
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
Sorrell TC; Packham DR; Shanker S; Foldes M; Munro R
Ann Intern Med; 1982 Sep; 97(3):344-50. PubMed ID: 7114631
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Apisarnthanarak A; Mundy LM
Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
[No Abstract] [Full Text] [Related]
17. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
18. [Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
Georges B; Brown L; Mazerolles M; Decun JF; Cougot P; Archambaud M; Suc C; Andrieu P; Virenque C
Presse Med; 1997 Apr; 26(11):502-6. PubMed ID: 9137379
[TBL] [Abstract][Full Text] [Related]
19. [A case report of sepsis and multiple lung abscess associated with purulent arthritis of knee joint due to methicillin resistant Staphylococcus aureus].
Watanabe K; Takase T; Kinoshita A; Ishino T; Kawabe H; Yamazumi T; Kono S; Hayashi T; Yamaguchi K; Hara K
Kansenshogaku Zasshi; 1988 Mar; 62(3):266-72. PubMed ID: 3147308
[No Abstract] [Full Text] [Related]
20. Comparison of fosfomycin and vancomycin therapy for experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
RodrÃguez A; Vicente MV; Olay T
Eur J Clin Microbiol; 1985 Dec; 4(6):603-5. PubMed ID: 3853984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
